The new immunosuppressants, the malononitrilamides MNA 279 and MNA 715, inhibit various graft-vs.-host diseases (GvHD) in rodents

Drugs under Experimental and Clinical Research

Volumn 23, Issue 5-6, 1997, Pages 167-173

  Schorlemmer, H U ^a   Kurrle, R ^a   Bartlett, R R ^b  

^a Behringwerke AG   (Germany)

^b Werk Kalle Albert   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 CYANO 3 HYDROXY N [4 (TRIFLUOROMETHYL)PHENYL] 6 HEPTYNAMIDE; 2 CYANO N (4 CYANOPHENYL) 3 CYCLOPROPYL 3 OXOPROPIONAMIDE; AUTOANTIBODY; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOSUPPRESSIVE AGENT; MALONONITRILE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DOSE RESPONSE; ERYTHROCYTE COUNT; GLOMERULONEPHRITIS; GRAFT VERSUS HOST REACTION; HEMATOCRIT; IMMUNE RESPONSE; LYMPH NODE; LYMPH NODE HYPERPLASIA; LYMPHADENOPATHY; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PROTEINURIA; RAT; SPLENOMEGALY; SURVIVAL RATE;

ALKYNES; ANIMALS; DISEASE MODELS, ANIMAL; GRAFT VS HOST DISEASE; GRAFT VS HOST REACTION; IMMUNOSUPPRESSIVE AGENTS; ISOXAZOLES; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPH NODES; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; NITRILES; RATS; RATS, INBRED BN; RATS, INBRED LEW;

EID: 0031350977     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Williamson R.A., Yea C.M., Robson P.A., et al. Dehydroorotate dehydrogenase is a high affinity binding protein for A771726 and mediator of a range of biological effects of the immunomodulatory compound. J. Biol. Chem., 270, 22467, 1995.
2. Kurrle R., Bartlett R.R., Lauffer L., Schorlemmer H.U. Malononitrilamides inhibit T-and B-cell responsiveness. Transplant. Proc., 28, 3053, 1996.
3. Kurrle R., Ruuth E., Bartlett R.R., Lauffer L., Schorlemmer H.U. Malononitrilamides inhibit T-and B-cell responsiveness in different species. Transplant. Proc., 29, 1302, 1997.
4. Morris R.E., Huang X., Cao W., Zheng B., Shorthouse R.A. Leflunomide (HWA 486) and its analog suppress T-and B-cell proliferation in vitro, acute rejection, ongoing rejection, and antidonor antibody synthesis in mouse, rat, and cynomolgus monkey transplant recipients as well as arterial intimal thickening after baloon catheter injury. Transplant. Proc., 27, 445, 1995.
5. Schorlemmer H.U., Schwab W., Ruuth E., Kurrle R. Acute skin graft rejection can be prevented and treated in rat models by malononitrilamides. Transplant. Proc., 28, 3048, 1996.
6. Lin Y., Segers C., Waer M. Efficacy of the malononitrilamide X 920715 as compared with leflunomide in cardiac allo-and xenotransplantation in rats. Transplant. Proc. 28, 3036, 1996.
7. Schorlemmer H.U., Kurrle R. Control of mouse-to-rat skin xenograft rejection by malononitrilamides. Transplant. Proc., 28, 3037, 1996.
8. Schorlemmer H.U., Brendel S., Bartlett R.R. Malononitrilamides prevent the development of marine systemic lupus erythematosus-like diseases in BDF1 hybrid mice and MRL/lpr autoimmune mice. Transplant. Proc., 28, 3040, 1996.
9. Ford W.L., Burr W., Simonsen G. A lymph node weight assay for the graft-versus-host activity of rat lymphoid cells. Transplantation, 10, 258, 1970.
10. Roudebush R.E., Brynat H.U. Pharmacologic manipulation of graft-versus-host induced splenomegaly. Agents Actions, 35, 260, 1992.
11. Gleichmann E., van Elven E.H., van der Veen J.P.W. A systemic lupus erythematosus (SLE)-like disease in mice induced by abnormal T-and B-cell cooperation. Preferential formation of autoantibodies characteristic of SLE. Eur. J. Immunol., 12, 152, 1982.